Author:
Brahimi Fouad,Rachid Zakaria,McNamee James P.,Alaoui-Jamali Moulay A.,Tari Ana M.,Jean-Claude Bertrand J.
Subject
Pharmacology,Biochemistry
Reference23 articles.
1. Epidermal growth factor receptor-negative tumours are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers;Koenders;Cancer Res,1991
2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
3. Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumour targeting strategy;Matheson;J Pharm Exp Ther,2001
4. Inhibition of epidermal growth factor receptor-mediated signaling by “combi-triazene” BJ2000, a new probe for the Combi-Targeting postulates;Brahimi;J Pharm Exp Ther,2002
5. The combi-targeting concept: a novel 3,3-disubstitued nitrosourea with EGFR tyrosine kinase inhibitory properties;Qiu;Cancer Chemother Pharmacol,2003
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献